Newly-released Aquaculture Vaccines Market industry analysis report by Future Market Insights shows that global sales of the Aquaculture Vaccines Market in 2022 were held at US$ 374.9 Million. With 8.5%, the projected market growth from 2023 to 2033 is expected to be higher than the historical growth. The Injected Vaccines are expected to be the significant revenue-generating segment, expected to account for a CAGR of 8.6% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Aquaculture Vaccines Market (2023) | US$ 406 Million |
| Global Aquaculture Vaccines Market (2033) | US$ 913.6 Million |
| Global Aquaculture Vaccines Market CAGR (2023 to 2033) | 8.5% |
| U.S. Aquaculture Vaccines Market CAGR (2023 to 2033) | 8.1% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Aquaculture Vaccines Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Aquaculture Vaccines Market industry increased at around 8.1% CAGR, wherein, countries such as the USA., UK, China, Japan, and South Korea held a significant share in the global market.
Vaccines are used to prevent a number of diseases in companion animals, as well as terrestrial cattle. In the aquaculture industry, diseases occur more frequently and replicate fast. The most significant variables to expand aquatic animal healthcare are general management and suitable husbandry, which include immunity, genetics, system management, nutrition, and water quality.
The ideal vaccination should be safe for the fish, the people vaccinating the fish, and the end-user, while also protecting against numerous diseases and assisting in the prevention of any sickness. It also provides long-term protection throughout the life cycle. Vaccines for aquaculture are produced in such a way that they are simple to use and may be used on a variety of fish species at the same time. One of the prime requirements of these vaccines is that they should be affordable, and must be licensed and registered with the FDA.
Vaccination of farmed fish provides considerable benefits in the fight against viral and bacterial infections while avoiding the negative side effects of medications. Antibiotic usage also leads to antibiotic resistance, which leads to a loss of aquaculture output and severe economic losses.
Antibiotics are no longer used in aquaculture operations in certain European nations, such as Norway. This has had a good impact on the market for aquaculture vaccinations, as well as minimizing the risk of antibiotic resistance. Furthermore, due to technological developments, the adoption of aquaculture vaccinations would grow as opposed to antibiotics, with the advent of DNA and subunit vaccines.
Principal Consultant
The aquaculture vaccines market in North America is expected to grow at a CAGR of 8%. Key businesses like Zoetis Inc. and Merck & Co. are increasing their research and development investments, which is boosting regional industry revenue. Furthermore, government financing for the development of aquaculture vaccines will boost market share.
Throughout the projected period, Europe will continue to be one of the most lucrative markets for commercial aquaculture vaccinations. For instance, Norway is one of the prominent salmon exporters globally, owing to its supportive government and private-sector activities, increased human concerns about antibiotic resistance, and the presence of key players.
The Norwegian Medicines Agency has particular regulations and standards for autogenous vaccination applications. Furthermore, autogenous vaccinations should only be utilized in the event that commercial vaccines are unavailable or do not provide sufficient protection. Under the 7th Framework Program, the European Commission supported a large-scale collaborative project to support the aquaculture industry.
Asia-Pacific is another lucrative market for aquaculture where several aquatic species, such as tilapia, are produced in abundance. Due to factors such as rising demand for marine foods, a developing aquaculture industry, the availability of sufficient water resources across key countries, supportive government initiatives, and the growing practice of sustainable aquaculture, the market in the Asia Pacific is expected to grow significantly throughout the forecast period.
The market for aquaculture vaccines in the USA is expected to reach a market size of US$309 Million by 2033. The market in the country is expected to swell at a CAGR of 8.1% from 2023 to 2033, with an absolute dollar opportunity of US$ 167 Million.
The market in the U.K. is expected to reach a valuation of US$ 41 Million by 2033. Growing with a CAGR of 9.8% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of US$ 13.7 Million.
In Japan, the market is expected to grow at a CAGR of 8% from 2023 to 2033, reaching US$ 29 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 15.6 Million during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2020, the inactivated vaccines held a significant market share of over 30%. Inactivated bacterial and viral vaccines are produced in huge numbers by fermenting disease-causing microorganisms. After that, inactivating chemicals like formalin are used to destroy all of the bacteria. Because they retain their basic shape, antigen properties, and structure, these inactivated organisms provoke an immunological response.
In 2020, the injected vaccines held a prominent market share of over 35%. Elanco's Apex-IHN is the first DNA vaccine to be approved in Canada for IHNV protection in healthy salmonid fish. Injectable Aquaculture Vaccines for protection against diseases such as vibriosis, furunculosis, winter sore, cold-water vibriosis, Infectious Salmon Anemia, and IPN, are a part of Zoetis' Alpha Ject portfolio.
During the projection period, revenue through oral vaccines is projected to grow at a CAGR of 8.7%. Oral immunization has several advantages over alternative delivery methods. The procedure is non-invasive, does not need handling of the fish, is simple to administer and can be used to immunize large groups of people. This contributes to the segment's expansion.
In 2020, the aquaculture vaccines market accounted for a share of over 43% through bacterial application. The USDA's Aquatic Animal Health Research has identified bacterial species from more than 20 genera as the causal agents of Aquatic illnesses. They have an impact on over 20 kinds of freshwater and marine fish. Aquatic infections cause enormous economic losses in the aquaculture business, with yearly losses estimated to be in the hundreds of millions of dollars.
During the projected period, the revenue through the viral application of aquaculture vaccines is expected to grow at a CAGR of around 9%. According to a report by the Responsible Use of Medicines in Agriculture Alliance (RUMA), the primary types of fish grown via aquaculture that are routinely vaccinated, are Atlantic salmon, rainbow trout, and Atlantic cod.
Companies in the commercial aquaculture vaccines industry are focusing on strategic acquisitions of new innovative firms and value chain alliances. Leading vaccine makers are working on the difficulties faced by aquaculture farmers and responding to their needs for sustainable fish aquaculture farming by releasing effective and easy-to-use commercial aquaculture vaccines. These initiatives are intended to help them increase their sales in the commercial aquaculture vaccines market around the world.
Some of the recent developments of key players in the Aquaculture Vaccines Market are as follows:
This collaboration is expected to provide Africa, Asia, and Latin America with a complete and novel spectrum of tilapia vaccinations. This strategy allowed the corporation to add value to its existing portfolio while also expanding its customer base into previously unexplored markets.
Similarly, recent developments related to companies offering Aquaculture Vaccines Market have been tracked by the team at Future Market Insights, which are available in the full report.
The global aquaculture vaccines market is valued at US$ 406 million in 2023.
There are various vaccines used in aquaculture such as attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines.
Asia Pacific is leading the aquaculture vaccines market.
The top five countries are Norway, Chile, Vietnam, China, and the United States.
Key trends shaping the market include rising demand for sustainable seafood and increased focus on disease prevention.
1. Executive Summary | Aquaculture Vaccines Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
& 4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Analysis, 2018 to 2022
6.2. Current and Future Market Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product Type, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
8.3.1. Attenuated Live Vaccines
8.3.2. Inactivated Vaccines
8.3.3. Subunit Vaccines
8.3.4. DNA Vaccines
8.3.5. Recombinant Vaccines
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Route of Administration, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
9.3.1. Oral
9.3.2. Injected
9.3.3. Immersion & Spray
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Bacterial
10.3.2. Viral
10.3.3. Parasitic
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. United States of America
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product Type
12.4.3. By Application
12.4.4. By Route of Administration
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Application
12.5.4. By Route of Administration
13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Argentina
13.4.1.4. Chile
13.4.1.5. Colombia
13.4.1.6. Peru
13.4.1.7. Ecuador
13.4.1.8. Rest of Latin America
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By Route of Administration
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.5.4. By Route of Administration
14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. United Kingdom
14.4.1.4. Italy
14.4.1.5. Spain
14.4.1.6. Norway
14.4.1.7. Denmark
14.4.1.8. Ireland
14.4.1.9. Rest of Europe
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By Route of Administration
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.5.4. By Route of Administration
15. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Taiwan
15.4.1.5. Indonesia
15.4.1.6. Malaysia
15.4.1.7. Singapore
15.4.1.8. Thailand
15.4.1.9. Philippines
15.4.1.10. Vietnam
15.4.1.11. Rest of Asia Pacific
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By Route of Administration
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.5.4. By Route of Administration
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
16.4.1. By Country
16.4.1.1. Saudi Arabia
16.4.1.2. South Africa
16.4.1.3. Israel
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By Route of Administration
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.5.4. By Route of Administration
17. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.2.2.1. By Product Type
17.2.2.2. By Application
17.2.2.3. By Route of Administration
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.3.2.1. By Product Type
17.3.2.2. By Application
17.3.2.3. By Route of Administration
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.4.2.1. By Product Type
17.4.2.2. By Application
17.4.2.3. By Route of Administration
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.5.2.1. By Product Type
17.5.2.2. By Application
17.5.2.3. By Route of Administration
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.6.2.1. By Product Type
17.6.2.2. By Application
17.6.2.3. By Route of Administration
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.7.2.1. By Product Type
17.7.2.2. By Application
17.7.2.3. By Route of Administration
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.8.2.1. By Product Type
17.8.2.2. By Application
17.8.2.3. By Route of Administration
17.9. Spain Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.9.2.1. By Product Type
17.9.2.2. By Application
17.9.2.3. By Route of Administration
17.10. UK Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.10.2.1. By Product Type
17.10.2.2. By Application
17.10.2.3. By Route of Administration
17.11. Norway Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.11.2.1. By Product Type
17.11.2.2. By Application
17.11.2.3. By Route of Administration
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.12.2.1. By Product Type
17.12.2.2. By Application
17.12.2.3. By Route of Administration
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.13.2.1. By Product Type
17.13.2.2. By Application
17.13.2.3. By Route of Administration
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.14.2.1. By Product Type
17.14.2.2. By Application
17.14.2.3. By Route of Administration
17.15. Saudi Arabia Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.15.2.1. By Product Type
17.15.2.2. By Application
17.15.2.3. By Route of Administration
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.16.2.1. By Product Type
17.16.2.2. By Application
17.16.2.3. By Route of Administration
17.17. Israel Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2022
17.17.2.1. By Product Type
17.17.2.2. By Application
17.17.2.3. By Route of Administration
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. IBM
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. SYMANTEC
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. MICRO FOCUS
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. QUALYS
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. SOLARWINDS
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. IVANTI
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. MANAGEENGINE
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. CONNECTWISE
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. AVAST
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. AUTOMOX
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Aquaculture Vaccines Market
